SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Chill Brands enters agreement for US CBD distribution

    By
    Home / Chill Brands enters agreement for US CBD distribution

    UK-based Chill Brands has entered into a brokerage agreement with Bellator Group LLC to support and expand US distribution of its product lines.

    Bellator will be working closely with Chill Brands‘ internal sales team to monitor market trends. 

    This will enable Chill Brands to gather more accurate data and adapt its sales plans to improve the uptake of Chill products by retail buyers and consumers.  

    Read more: Former GSK counsel joins CBD group Chill Brands

    CEO of Chill Brands, Callum Sommerton, commented: “We are thrilled to be working with Bellator Group to refine our approach to retail sales. 

    “This relationship forms part of our strategy to work more closely with retailers, ensuring that our products are given the best possible chance to perform. 

    “As an established specialist broker for the CBD industry, Bellator has an extensive network of connections and the expertise required to generate success in our primary product category.”

    As well as developing and acting on commercial insights across a significant proportion of the Chill Brand’s existing distribution channels, Bellator will also market Chill’s CBD range and potential future product extensions to its wider network of retail contacts.

    Co-founder of Bellator Group, Shane Nance, said: “We are excited to work with Chill Brands to help support their existing distribution channels and develop new ones. 

    “We have been extremely impressed with their quality product line-up and the Chill brand itself which, with the right vision and execution, has the potential to truly stand out in the retail environment.”

    [activecampaign form=31]

    10 June 2026 · Berlin Sales end May 29

    European Cannabis
    Insights Summit

    From €216

    200+ industry leaders. Exclusive German market data. A half-day briefing for B2B operators in Europe's most important emerging cannabis market.

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free